StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > CRAZY price for 2 clinics!

<< Previous

Bullboard Posts

Next >>

Post by mountainposeon Apr 01, 2021 12:53pm

165 Views

Post# 32923502

CRAZY price for 2 clinics!

 		ONLY 2 Care clinics. One in UK and other in USA. Phones don't answer with a real person also the industry is in trouble. Crazy price to pay for a bit of Quackery. Serious problems here.

 		TULSA, Okla. — The Cancer Treatment Centers of America in Tulsa has announced they are closing their doors this summer. The CTCA near 81st and Mingo has served the Tulsa community for more than 30 years and employs more than 400 people.

 		A statement sent by the CTCA says, “Despite working tirelessly to overcome significant patient access and insurance limitations that inexplicably restrict patient care options and prevent patient choice in this market, CTCA Tulsa will close operations as of June 1, 2021. "